Annual Meeting Media Resource Center

KEY DATES

  • Media registration opens: March 2
  • Hotel reservation deadline: April 22
  • Embargoed presscast for media: May 13
  • Final deadline for pre-registration: May 22
  • 2015 ASCO Annual Meeting: May 29 - June 2

MEDIA AND EMBARGO POLICIES

REGISTER TO ATTEND THE MEETING

To submit a registration request for an upcoming meeting, please visit ASCO's Media Headquarters. The final deadline for pre-registration is Friday, May 22.

For further questions about registration, or how to navigate the Media Headquarters site, please contact mediaregistration@asco.org.

ACCESS EMBARGOED MATERIALS

Even if you will not be attending the meeting on-site in Chicago, you can still request access to embargoed meeting information. To submit a request, please visit ASCO's Media Headquarters.

You will be notified via email within two to three business days regarding the status of your request. Once your request is approved, you will have access to embargoed information leading up to and throughout the meeting.

For questions about how to navigate the Media Headquarters site, please contact mediaregistration@asco.org.

PRESS RELEASES

Advances in Treatment of Melanoma, Oral Cancer, Brain Metastases, and Childhood Cancers Presented at ASCO’s Annual Meeting
CHICAGO – Findings presented today at the 51st Annual Meeting of the American Society of Clinical Oncology (ASCO) provide long-sought, conclusive answers about the impact of less aggressive therapy on childhood cancer survival; the optimal timing of surgery for oral cancer; and the use of whole-brain radiation for patients with brain metastases. Another study provides a powerful new immunotherapy option for patients with melanoma. Read the full release.

Studies Offer Improved Treatments for Diverse Set of Common and Rare Cancers
CHICAGO – Results from five late-breaking studies released today at the American Society of Clinical Oncology’s (ASCO) 51st Annual Meeting provide important new treatment options for patients with common and rare cancers. Read the full release.

New Targeted Treatments for Blood Cancers Show Promise
CHICAGO – Results from four pivotal clinical trials show that new targeted therapies could vastly improve treatment for people with chronic-lymphocytic leukemia (CLL), myelofibrosis, indolent non-Hodgkin lymphoma (NHL), and multiple myeloma. Read the full release.

New Immunotherapies for Multiple Hard-to-Treat Cancers
CHICAGO – Findings from four clinical trials released today at the American Society of Clinical Oncology’s (ASCO) 51st Annual Meeting show a promising new role for immunotherapy in patients with a wide range of common, solid tumor cancers. Read the full release.

New Cancer Treatment and Prevention Studies Signal Major Advances for Children and Adults
ALEXANDRIA, Va. – The American Society of Clinical Oncology (ASCO) today announced results from four major studies to be presented at ASCO’s 51st Annual Meeting, May 29-June 2, in Chicago. Findings showed that use of a widely available vitamin pill reduces the risk of non-melanoma skin cancers; that early chemotherapy extends the lives of men with advanced prostate cancers; and that new therapies can improve outcomes for children with a rare form of kidney cancer and adults with relapsed multiple myeloma. Read the full release.

2015 ASCO Annual Meeting Press Program to Highlight Advances in Cancer Treatment, Prevention, and Patient Care
ALEXANDRIA, Va. – The American Society of Clinical Oncology (ASCO) today announced the studies to be featured in the 2015 ASCO Annual Meeting press program. They represent advances against an array of cancers and in nearly every major area of cancer patient care, including immunotherapy, targeted treatments, surgery, radiation, cancer prevention, and innovative strategies to improve patients’ quality of life. Read the full release.

VIEW RECORDINGS OF PAST PRESS BRIEFINGS

Visit the ASCO Video Gallery to view recordings of the May 13 virtual presscast and on-site press briefings.

STREAM THE ON-SITE PRESS BRIEFINGS LIVE

To watch a live recording of the on-site press briefings, please follow the instructions below  when the briefing begins:

To join the webinar portion:

  1. Click here.
  2. Enter your name and email address.
  3. Click 'Enter.'

To join the teleconference portion:

  1. Call 1-877-668-4493 (U.S./Canada toll-free number).
  2. For global dial-in numbers, click here.
  3. Enter the access code 735 054 883

ON-SITE PRESS FACILITIES

Information about the on-site press facilities (press room location, hours, etc.)

MEETING PUBLICATIONS

MEETING INFORMATION

MEDIA RESOURCES


Cancer.Net: ASCO’s award-winning patient website, provides comprehensive, oncologist-approved information on more than 120 cancer types, together with expert information on cancer treatments, managing side effects and coping with a cancer diagnosis. When the site first launched in 2002, there were detailed sections on 22 different types of cancer. Now, Cancer.Net continues to lead the way in content, design, and interactivity, providing patients, their families and friends with timely and authoritative information.

CancerProgress.Net: offers a detailed, interactive timeline of advances against 17 of the most common cancers. The site also includes simple, interactive charts on cancer survival, mortality, and incidence, along with downloadable timelines, historical commentary and other reporting resources.

Visit the Virtual Press Room to view third party press releases related to the 2015 ASCO Annual Meeting
 

HOW CAN WE HELP YOU?

Interview Requests
mediateam@asco.org
Please do not send media registration requests to this email address.

Media Registration Questions
mediaregistration@asco.org

Questions About Annual Meeting Embargo Policies
commpolicies@asco.org
All requests must be submitted in writing.

Broadcasting Live from the Meeting
Wendy Stokes, wendy.stokes@asco.org

General Questions About the Meeting
Wendy Stokes, wendy.stokes@asco.org
Alise Fisher, alise.fisher@asco.org